{
    "hands_on_practices": [
        {
            "introduction": "The first major hurdle in gene delivery is the cell membrane, a barrier that repels negatively charged nucleic acids like DNA. This practice explores the foundational strategy used to overcome this: complexing the DNA with positively charged carriers. By comparing the transfection efficiency of naked DNA against cationic lipid (lipoplex) and polymer (polyplex) formulations, you will quantify their effectiveness and grapple with the fundamental trade-offs between delivery efficiency and cellular toxicity. ",
            "id": "5067789",
            "problem": "A laboratory is comparing three non-viral gene delivery methods in a single immortalized mammalian cell line under equal nucleic acid dose constraints, using a reporter plasmid encoding a fluorescent protein to quantify successful transfection. The three methods are cationic lipid–DNA complexes (lipoplexes), cationic polymer–DNA complexes (polyplexes), and naked DNA. Under identical culture conditions and equal DNA mass delivered per well, the observed fractions of cells that express the reporter after a fixed incubation are as follows: lipoplexes yield a transfection efficiency of $0.35$, polyplexes yield $0.25$, and naked DNA yields $0.05$.\n\nStarting from first principles, treat transfection efficiency as the probability that a cell becomes transgene-positive under a single exposure at the specified dose, and define the relative improvement of method $A$ over reference $B$ as\n$$R_{A|B} = \\frac{E_{A} - E_{B}}{E_{B}},$$\nwhere $E_{A}$ and $E_{B}$ are the transfection efficiencies of methods $A$ and $B$, respectively. Use the provided efficiencies to compute the three relative improvements $R_{\\text{lipoplex}|\\text{naked}}$, $R_{\\text{polyplex}|\\text{naked}}$, and $R_{\\text{lipoplex}|\\text{polyplex}}$.\n\nThen, under the same equal dose constraints, discuss conceptually the trade-offs among these methods with respect to off-target expression and cytotoxicity, grounding your reasoning in core definitions and well-tested biological facts such as the Central Dogma and the electrostatic interactions between cationic carriers and anionic cellular membranes. Do not introduce any new numerical parameters.\n\nProvide your final computed values as a row matrix in the order $R_{\\text{lipoplex}|\\text{naked}}$, $R_{\\text{polyplex}|\\text{naked}}$, $R_{\\text{lipoplex}|\\text{polyplex}}$. No rounding is required.",
            "solution": "The problem is assessed as valid. It is scientifically grounded in the principles of molecular biology and gene delivery, well-posed with sufficient data for calculation, and objective in its phrasing. The problem requires both a quantitative calculation and a conceptual discussion, both of which are based on established scientific facts.\n\nThe problem asks for two tasks: first, to compute three relative improvement metrics based on provided transfection efficiencies, and second, to conceptually discuss the trade-offs among the gene delivery methods.\n\n**Part 1: Calculation of Relative Improvement**\n\nThe problem provides the transfection efficiencies for three methods:\n- Cationic lipid–DNA complexes (lipoplexes): $E_{\\text{lipoplex}} = 0.35$\n- Cationic polymer–DNA complexes (polyplexes): $E_{\\text{polyplex}} = 0.25$\n- Naked DNA: $E_{\\text{naked}} = 0.05$\n\nThe relative improvement of method $A$ over a reference method $B$ is defined by the formula:\n$$R_{A|B} = \\frac{E_{A} - E_{B}}{E_{B}}$$\n\nWe are required to compute three specific relative improvements.\n\n1.  **Relative improvement of lipoplexes over naked DNA ($R_{\\text{lipoplex}|\\text{naked}}$):**\n    Using the given formula with $A = \\text{lipoplex}$ and $B = \\text{naked}$:\n    $$R_{\\text{lipoplex}|\\text{naked}} = \\frac{E_{\\text{lipoplex}} - E_{\\text{naked}}}{E_{\\text{naked}}}$$\n    Substituting the given efficiency values:\n    $$R_{\\text{lipoplex}|\\text{naked}} = \\frac{0.35 - 0.05}{0.05} = \\frac{0.30}{0.05} = 6$$\n    This result indicates that the lipoplex method is $600\\%$ more efficient than using naked DNA under these conditions.\n\n2.  **Relative improvement of polyplexes over naked DNA ($R_{\\text{polyplex}|\\text{naked}}$):**\n    Using the given formula with $A = \\text{polyplex}$ and $B = \\text{naked}$:\n    $$R_{\\text{polyplex}|\\text{naked}} = \\frac{E_{\\text{polyplex}} - E_{\\text{naked}}}{E_{\\text{naked}}}$$\n    Substituting the given efficiency values:\n    $$R_{\\text{polyplex}|\\text{naked}} = \\frac{0.25 - 0.05}{0.05} = \\frac{0.20}{0.05} = 4$$\n    This result indicates that the polyplex method is $400\\%$ more efficient than using naked DNA.\n\n3.  **Relative improvement of lipoplexes over polyplexes ($R_{\\text{lipoplex}|\\text{polyplex}}$):**\n    Using the given formula with $A = \\text{lipoplex}$ and $B = \\text{polyplex}$:\n    $$R_{\\text{lipoplex}|\\text{polyplex}} = \\frac{E_{\\text{lipoplex}} - E_{\\text{polyplex}}}{E_{\\text{polyplex}}}$$\n    Substituting the given efficiency values:\n    $$R_{\\text{lipoplex}|\\text{polyplex}} = \\frac{0.35 - 0.25}{0.25} = \\frac{0.10}{0.25} = 0.4$$\n    This result indicates that the lipoplex method is $40\\%$ more efficient than the polyplex method.\n\n**Part 2: Conceptual Discussion of Trade-offs**\n\nThe observed differences in transfection efficiency and the associated trade-offs regarding cytotoxicity and off-target expression can be explained from first principles, specifically electrostatic interactions and the Central Dogma of molecular biology.\n\n**Efficiency and Electrostatic Interactions:**\nThe fundamental challenge in gene delivery is to overcome the electrostatic repulsion between the anionic nucleic acid and the anionic cell membrane.\n- Deoxyribonucleic Acid (DNA) is a polyanion due to the negatively charged phosphate groups ($\\text{PO}_4^{3-}$) in its sugar-phosphate backbone.\n- The outer surface of a mammalian cell membrane is also net-negative, primarily due to the head groups of phospholipids (e.g., phosphatidylserine) and sialic acid residues on membrane glycoproteins.\n- Consequently, there is a strong electrostatic repulsion between naked DNA and the cell surface. This repulsion acts as a significant barrier to cellular uptake, explaining the very low efficiency ($E_{\\text{naked}} = 0.05$) of naked DNA delivery.\n- Both lipoplexes and polyplexes utilize cationic (positively charged) molecules—lipids and polymers, respectively—to overcome this barrier. These cationic agents spontaneously complex with the anionic DNA through electrostatic interactions. The formulation is typically adjusted to create a complex with a net positive surface charge. This net-positive charge promotes strong electrostatic attraction to the negatively charged cell surface, facilitating binding and subsequent internalization, predominantly via endocytosis. This charge-mediated interaction is the principal reason for the dramatically higher efficiencies of lipoplexes ($E_{\\text{lipoplex}} = 0.35$) and polyplexes ($E_{\\text{polyplex}} = 0.25$) compared to naked DNA.\n\n**Cytotoxicity:**\nThe very property that renders cationic carriers effective—their positive charge—is also the primary source of their cytotoxicity. This represents a critical trade-off between efficiency and cell viability.\n- Cationic lipids and polymers, being amphiphilic and charged, can act as detergents. At sufficient concentrations, they can non-specifically interact with and disrupt the lipid bilayer of the cell membrane, compromising its integrity and leading to leakage and cell lysis (necrosis).\n- Even after internalization, these cationic agents can destabilize the membranes of endosomes (a desired effect for payload release) and other organelles, such as mitochondria. Disruption of the mitochondrial membrane potential is a potent trigger for programmed cell death (apoptosis).\n- Therefore, a higher net positive charge on the delivery complex, which generally correlates with higher transfection efficiency, also tends to correlate with higher cytotoxicity. The choice of delivery agent is often a compromise to maximize gene delivery while minimizing cell death. Naked DNA, being a natural biological molecule, has negligible intrinsic cytotoxicity associated with its delivery.\n\n**Off-Target Expression and the Central Dogma:**\nThe Central Dogma states that genetic information flows from DNA to RNA to protein (DNA $\\xrightarrow{\\text{transcription}}$ RNA $\\xrightarrow{\\text{translation}}$ protein). For the reporter plasmid to be expressed, it must first enter the cytoplasm, then traffic to the nucleus where transcription occurs. The resulting messenger RNA (mRNA) is then exported to the cytoplasm for translation into the fluorescent protein.\n- The term \"off-target expression\" in this context refers to undesirable consequences of gene delivery. One major concern is insertional mutagenesis. A plasmid is an extrachromosomal piece of DNA, leading to transient expression as it does not replicate with the cell's genome and is diluted out through cell division. However, there is a low but finite probability that the plasmid may randomly integrate into the host cell's chromosomes.\n- Such random integration is an off-target event. If the integration occurs within a functional gene (e.g., a tumor suppressor gene like $p53$), it can disrupt its function. If it occurs near a proto-oncogene, it can lead to its inappropriate activation. Both scenarios can contribute to carcinogenesis.\n- The risk of this off-target effect is directly related to the amount of plasmid DNA that successfully reaches the nucleus. Methods with higher efficiency, like lipofection and polyfection, deliver a larger quantity of DNA into the nuclear compartment compared to the negligible amount delivered by naked DNA. Therefore, while more efficient, they also carry a statistically higher risk of promoting rare but dangerous off-target integration events. The non-specific, charge-based binding mechanism of cationic carriers also means that in a more complex _in vivo_ system, they would deliver genes to many cell types non-selectively, another form of off-target effect.\n- In summary, there is an inherent trade-off: naked DNA is very safe but ineffective; cationic carriers are effective but introduce risks of cytotoxicity and off-target genetic modifications.",
            "answer": "$$ \\boxed{ \\begin{pmatrix} 6 & 4 & 0.4 \\end{pmatrix} } $$"
        },
        {
            "introduction": "Successfully entering a cell via endocytosis is not the end of the journey; it's the beginning of a race against time. The gene delivery vehicle is often trapped within an endosome, a cellular compartment that can shuttle its contents towards degradation. This exercise models the critical process of 'endosomal escape' as a probabilistic journey, allowing you to calculate the fraction of payload that successfully reaches the cytosol before being destroyed. ",
            "id": "5067766",
            "problem": "A non-viral gene delivery vehicle such as a cationic lipid–nucleic acid complex enters a mammalian cell via endocytosis and experiences sequential endosomal trafficking steps. At each step, the cargo can experience one of three mutually exclusive outcomes: escape to the cytosol, enzymatic degradation within the endosome, or continued trafficking without escape or degradation to the next endosomal compartment. Assume that the probability of endosomal escape per step is $p_{e}$, the probability of degradation per step is $p_{d}$, and these probabilities are constant across steps and independent between steps. Let the number of trafficking steps considered be $n$.\n\nStarting from the rules of probability for mutually exclusive and independent events, derive an expression for the expected fraction of cargo that reaches the cytosol within $n$ steps, and then compute its value for $p_{e}=0.2$, $p_{d}=0.5$, and $n=3$. Round your final numeric answer to four significant figures and express it as a decimal. Do not use a percentage sign.",
            "solution": "The problem statement is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n### Step 1: Extract Givens\n- A non-viral gene delivery vehicle undergoes $n$ sequential endosomal trafficking steps.\n- At each step, there are three mutually exclusive outcomes:\n    1. Escape to the cytosol, with probability $p_e$.\n    2. Enzymatic degradation, with probability $p_d$.\n    3. Continued trafficking.\n- The probabilities $p_e$ and $p_d$ are constant across all steps.\n- The outcomes at each step are independent of previous steps.\n- The number of steps is $n$.\n- Task 1: Derive an expression for the expected fraction of cargo that reaches the cytosol within $n$ steps.\n- Task 2: Compute this value for $p_e=0.2$, $p_d=0.5$, and $n=3$.\n- Final answer must be a decimal rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded**: The problem describes a simplified, but standard and accepted, probabilistic model for endosomal escape, a critical barrier in non-viral gene delivery. The concepts of endocytosis, endosomal trafficking, degradation, and escape are fundamental to the field. The model is a valid abstraction of a real biological process.\n2.  **Well-Posed**: The problem is clearly defined with all necessary parameters and assumptions (constant independent probabilities, mutual exclusivity) to derive a unique mathematical expression and compute a numerical value. The sum of probabilities for all outcomes at a step must be $1$. The problem gives two probabilities, $p_e$ and $p_d$, for two of three mutually exclusive outcomes. This implies the third probability, for continued trafficking ($p_c$), is determined by $p_c = 1 - p_e - p_d$. For the given values, $p_c = 1 - 0.2 - 0.5 = 0.3$, which is a valid probability ($0 \\le p_c \\le 1$). The problem is self-contained and consistent.\n3.  **Objective**: The problem is stated in precise, unbiased, and mathematical language.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A full solution will be provided.\n\n### Derivation of the Expression\nLet $F_n$ be the expected fraction of cargo that escapes to the cytosol within $n$ trafficking steps. At each step, the cargo can escape, be degraded, or continue to the next step. Let the probabilities of these outcomes be $p_e$, $p_d$, and $p_c$, respectively. Since these three outcomes are mutually exclusive and exhaustive, their probabilities sum to $1$.\n$$p_e + p_d + p_c = 1$$\nFrom this, the probability of continued trafficking at any given step is:\n$$p_c = 1 - p_e - p_d$$\nFor a particle to escape at a specific step $k$ (where $1 \\le k \\le n$), it must first \"survive\" the preceding $k-1$ steps without escaping or being degraded. This means it must have undergone continued trafficking for $k-1$ steps. The probability of this event, due to the independence of steps, is $(p_c)^{k-1}$. After surviving $k-1$ steps, the particle must then escape at step $k$, an event with probability $p_e$.\n\nThe probability of the specific sequence of events leading to escape precisely at step $k$ is the product of these probabilities:\n$$P(\\text{escape at step } k) = (p_c)^{k-1} p_e$$\nThe total fraction of cargo escaping within $n$ steps, $F_n$, is the sum of the probabilities of escaping at step $1$, or step $2$, ..., or step $n$. Since escape at different steps are mutually exclusive events, we can sum their probabilities:\n$$F_n = \\sum_{k=1}^{n} P(\\text{escape at step } k) = \\sum_{k=1}^{n} p_e (p_c)^{k-1}$$\nWe can factor out the constant $p_e$:\n$$F_n = p_e \\sum_{k=1}^{n} (p_c)^{k-1}$$\nThe summation is a finite geometric series. Let a new index $j = k-1$. As $k$ goes from $1$ to $n$, $j$ goes from $0$ to $n-1$:\n$$\\sum_{k=1}^{n} (p_c)^{k-1} = \\sum_{j=0}^{n-1} (p_c)^{j}$$\nThe formula for the sum of a finite geometric series is $\\sum_{j=0}^{m} r^j = \\frac{1-r^{m+1}}{1-r}$. Here, $r = p_c$ and $m = n-1$. Applying the formula:\n$$\\sum_{j=0}^{n-1} (p_c)^{j} = \\frac{1 - (p_c)^{(n-1)+1}}{1-p_c} = \\frac{1 - (p_c)^{n}}{1-p_c}$$\nSubstituting this result back into the expression for $F_n$:\n$$F_n = p_e \\left( \\frac{1 - (p_c)^{n}}{1-p_c} \\right)$$\nFinally, we substitute $p_c = 1 - p_e - p_d$ back into the denominator $1-p_c = 1 - (1-p_e-p_d) = p_e+p_d$. The derived expression for the expected fraction of escaped cargo is:\n$$F_n = p_e \\left( \\frac{1 - (1 - p_e - p_d)^{n}}{p_e+p_d} \\right)$$\n\n### Numerical Computation\nWe are asked to compute the value of $F_n$ for $p_e=0.2$, $p_d=0.5$, and $n=3$.\nFirst, let's calculate the probability of continued trafficking, $p_c$:\n$$p_c = 1 - p_e - p_d = 1 - 0.2 - 0.5 = 0.3$$\nNow, we substitute these values into the derived expression for $F_n$:\n$$F_3 = p_e \\left( \\frac{1 - (p_c)^{3}}{1-p_c} \\right) = 0.2 \\left( \\frac{1 - (0.3)^{3}}{1-0.3} \\right)$$\nWe calculate the terms:\n$$(0.3)^{3} = 0.3 \\times 0.3 \\times 0.3 = 0.027$$\n$$1 - (0.3)^{3} = 1 - 0.027 = 0.973$$\n$$1 - 0.3 = 0.7$$\nSubstituting these back into the equation for $F_3$:\n$$F_3 = 0.2 \\left( \\frac{0.973}{0.7} \\right)$$\n$$F_3 = \\frac{0.2 \\times 0.973}{0.7} = \\frac{0.1946}{0.7}$$\n$$F_3 = 0.278$$\nThe problem requires the final answer to be rounded to four significant figures. The calculated value $0.278$ has three significant figures. To express this with four significant figures, we add a trailing zero.\n$$F_3 = 0.2780$$",
            "answer": "$$\\boxed{0.2780}$$"
        },
        {
            "introduction": "Once the genetic payload reaches its destination—the cytosol for messenger RNA (mRNA) or the nucleus for plasmid DNA (pDNA)—the final step is expressing the encoded protein. The choice of payload has profound implications for the timing and duration of this expression. This practice challenges you to model and compare the expression kinetics of direct mRNA delivery versus pDNA delivery, revealing the distinct profiles of rapid-but-transient versus delayed-but-sustained protein production that guide therapeutic applications. ",
            "id": "5067747",
            "problem": "A biotechnology team is comparing two non-viral gene delivery modalities for a reporter gene after a single intramuscular administration at time $t=0$: (i) lipid nanoparticle delivery of messenger ribonucleic acid (mRNA), and (ii) polymeric polyplex delivery of plasmid deoxyribonucleic acid (plasmid DNA). Assume translation is not rate-limiting so that the instantaneous protein production rate (the “expression profile”) is proportional to the cytosolic mRNA abundance. Use first-order kinetics and the relation between half-life and first-order rate constant, namely $\\lambda = (\\ln 2)/T_{1/2}$.\n\nModality (i), direct mRNA delivery: an initial cytosolic mRNA amount $M_{0}$ is present at $t=0$ and decays with half-life $T_{1/2,\\mathrm{mRNA}}=6\\,\\mathrm{h}$ by first-order kinetics.\n\nModality (ii), plasmid DNA delivery: transcriptionally active plasmid copies in the nucleus, $D(t)$, decay with half-life $T_{1/2,\\mathrm{pDNA}}=24\\,\\mathrm{h}$ by first-order kinetics due to degradation and dilution. Transcription produces mRNA at a rate proportional to $D(t)$ with proportionality constant $k_{\\mathrm{tx}}$ (with units of mRNA per plasmid per hour). Cytosolic mRNA degrades by first-order kinetics with the same half-life $T_{1/2,\\mathrm{mRNA}}=6\\,\\mathrm{h}$. There is no pre-existing mRNA from plasmid at $t=0$, so $M(0)=0$.\n\nStarting from these assumptions and definitions (including the Central Dogma of Molecular Biology and first-order decay), do the following:\n\n1. Derive the expression profiles $E_{\\mathrm{mRNA}}(t)$ and $E_{\\mathrm{pDNA}}(t)$, each proportional to the corresponding cytosolic mRNA abundance under modalities (i) and (ii), respectively, in closed form.\n\n2. Determine the times $t_{\\mathrm{mRNA}}^{\\ast}$ and $t_{\\mathrm{pDNA}}^{\\ast}$ at which $E_{\\mathrm{mRNA}}(t)$ and $E_{\\mathrm{pDNA}}(t)$ attain their maxima under these kinetics.\n\nReport both peak times in hours. Round your answer to four significant figures. Provide your final answer as a single row matrix $\\begin{pmatrix} t_{\\mathrm{mRNA}}^{\\ast} & t_{\\mathrm{pDNA}}^{\\ast} \\end{pmatrix}$.",
            "solution": "The problem statement is evaluated for validity.\n\n### Step 1: Extract Givens\n- **Topic**: Comparison of two non-viral gene delivery modalities: (i) lipid nanoparticle delivery of mRNA and (ii) polymeric polyplex delivery of plasmid DNA.\n- **Time**: Single administration at $t=0$.\n- **Assumption**: Instantaneous protein production rate (expression profile) is proportional to the cytosolic mRNA abundance.\n- **Kinetics**: All processes follow first-order kinetics.\n- **Rate Constant Relation**: $\\lambda = (\\ln 2)/T_{1/2}$.\n\n- **Modality (i) - mRNA delivery**:\n  - Initial cytosolic mRNA: $M_0$ at $t=0$.\n  - mRNA half-life: $T_{1/2,\\mathrm{mRNA}}=6\\,\\mathrm{h}$.\n\n- **Modality (ii) - plasmid DNA delivery**:\n  - Plasmid amount: $D(t)$.\n  - Plasmid half-life: $T_{1/2,\\mathrm{pDNA}}=24\\,\\mathrm{h}$.\n  - Transcription rate: proportional to $D(t)$ with constant $k_{\\mathrm{tx}}$.\n  - mRNA half-life: $T_{1/2,\\mathrm{mRNA}}=6\\,\\mathrm{h}$.\n  - Initial mRNA amount: $M(0)=0$.\n\n- **Tasks**:\n  1. Derive the expression profiles $E_{\\mathrm{mRNA}}(t)$ and $E_{\\mathrm{pDNA}}(t)$, which are proportional to the cytosolic mRNA abundance for each modality.\n  2. Determine the times $t_{\\mathrm{mRNA}}^{\\ast}$ and $t_{\\mathrm{pDNA}}^{\\ast}$ at which these profiles are maximal.\n- **Reporting**: Report peak times in hours, rounded to four significant figures, as a row matrix $\\begin{pmatrix} t_{\\mathrm{mRNA}}^{\\ast} & t_{\\mathrm{pDNA}}^{\\ast} \\end{pmatrix}$.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem uses a standard, simplified model of gene expression based on first-order kinetics for production and degradation. This is a common and valid approach in pharmacokinetics and systems biology. The half-life values are biologically plausible.\n- **Well-Posed**: The problem provides sufficient information, including initial conditions and governing kinetic laws, to formulate and solve the differential equations for the system. The requested quantities (expression profiles and their peak times) are well-defined mathematical objectives.\n- **Objective**: The problem is stated in precise, quantitative terms, free from subjectivity or ambiguity in its scientific premises.\n\nThe problem is scientifically sound, well-posed, objective, and contains no internal contradictions or missing information essential for its solution.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\n### Solution Derivation\n\nFirst, we define the first-order rate constants ($\\lambda$) from the given half-lives ($T_{1/2}$).\nThe rate constant for mRNA decay is:\n$$ \\lambda_{\\mathrm{mRNA}} = \\frac{\\ln 2}{T_{1/2,\\mathrm{mRNA}}} = \\frac{\\ln 2}{6} \\, \\mathrm{h}^{-1} $$\nThe rate constant for plasmid DNA decay is:\n$$ \\lambda_{\\mathrm{pDNA}} = \\frac{\\ln 2}{T_{1/2,\\mathrm{pDNA}}} = \\frac{\\ln 2}{24} \\, \\mathrm{h}^{-1} $$\n\n**Part 1: Derivation of Expression Profiles**\n\n**Modality (i): Direct mRNA Delivery**\nLet $M_i(t)$ be the amount of cytosolic mRNA at time $t$. The process is a simple first-order decay. The governing differential equation is:\n$$ \\frac{dM_i(t)}{dt} = -\\lambda_{\\mathrm{mRNA}} M_i(t) $$\nWith the initial condition $M_i(0)=M_0$, the solution is:\n$$ M_i(t) = M_0 \\exp(-\\lambda_{\\mathrm{mRNA}} t) $$\nThe expression profile, $E_{\\mathrm{mRNA}}(t)$, is proportional to $M_i(t)$. Let the proportionality constant be $k_p$.\n$$ E_{\\mathrm{mRNA}}(t) = k_p M_i(t) = k_p M_0 \\exp(-\\lambda_{\\mathrm{mRNA}} t) $$\nTo simplify, let $A = k_p M_0$ be a positive constant.\n$$ E_{\\mathrm{mRNA}}(t) = A \\exp(-\\lambda_{\\mathrm{mRNA}} t) $$\n\n**Modality (ii): Plasmid DNA Delivery**\nFirst, we find the amount of transcriptionally active plasmid, $D(t)$. Its decay is first-order with an initial amount $D_0$:\n$$ D(t) = D_0 \\exp(-\\lambda_{\\mathrm{pDNA}} t) $$\nLet $M_{ii}(t)$ be the amount of cytosolic mRNA at time $t$. The rate of change of $M_{ii}(t)$ is the rate of production (transcription) minus the rate of degradation.\n$$ \\frac{dM_{ii}(t)}{dt} = (\\text{rate of production}) - (\\text{rate of decay}) $$\n$$ \\frac{dM_{ii}(t)}{dt} = k_{\\mathrm{tx}} D(t) - \\lambda_{\\mathrm{mRNA}} M_{ii}(t) $$\nSubstituting the expression for $D(t)$, we get a first-order linear ordinary differential equation:\n$$ \\frac{dM_{ii}(t)}{dt} + \\lambda_{\\mathrm{mRNA}} M_{ii}(t) = k_{\\mathrm{tx}} D_0 \\exp(-\\lambda_{\\mathrm{pDNA}} t) $$\nWe solve this ODE using an integrating factor $I(t) = \\exp(\\int \\lambda_{\\mathrm{mRNA}} dt) = \\exp(\\lambda_{\\mathrm{mRNA}} t)$.\n$$ \\frac{d}{dt} \\left[ M_{ii}(t) \\exp(\\lambda_{\\mathrm{mRNA}} t) \\right] = k_{\\mathrm{tx}} D_0 \\exp(-\\lambda_{\\mathrm{pDNA}} t) \\exp(\\lambda_{\\mathrm{mRNA}} t) = k_{\\mathrm{tx}} D_0 \\exp((\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}) t) $$\nIntegrating both sides with respect to $t$:\n$$ M_{ii}(t) \\exp(\\lambda_{\\mathrm{mRNA}} t) = \\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} \\exp((\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}) t) + C $$\nSolving for $M_{ii}(t)$:\n$$ M_{ii}(t) = \\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} \\exp(-\\lambda_{\\mathrm{pDNA}} t) + C \\exp(-\\lambda_{\\mathrm{mRNA}} t) $$\nUsing the initial condition $M_{ii}(0) = 0$:\n$$ 0 = \\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} (1) + C (1) \\implies C = -\\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} $$\nSubstituting $C$ back into the equation for $M_{ii}(t)$:\n$$ M_{ii}(t) = \\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} \\left( \\exp(-\\lambda_{\\mathrm{pDNA}} t) - \\exp(-\\lambda_{\\mathrm{mRNA}} t) \\right) $$\nThe expression profile $E_{\\mathrm{pDNA}}(t)$ is proportional to $M_{ii}(t)$:\n$$ E_{\\mathrm{pDNA}}(t) = k_p M_{ii}(t) = k_p \\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} \\left( \\exp(-\\lambda_{\\mathrm{pDNA}} t) - \\exp(-\\lambda_{\\mathrm{mRNA}} t) \\right) $$\nLet $B = k_p \\frac{k_{\\mathrm{tx}} D_0}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}}$, which is a positive constant since $\\lambda_{\\mathrm{mRNA}} > \\lambda_{\\mathrm{pDNA}}$.\n$$ E_{\\mathrm{pDNA}}(t) = B \\left( \\exp(-\\lambda_{\\mathrm{pDNA}} t) - \\exp(-\\lambda_{\\mathrm{mRNA}} t) \\right) $$\n\n**Part 2: Determination of Peak Times**\n\nTo find the time of maximum expression, we find the derivative of each expression profile with respect to time and set it to zero.\n\n**Time $t_{\\mathrm{mRNA}}^{\\ast}$**\n$$ E_{\\mathrm{mRNA}}(t) = A \\exp(-\\lambda_{\\mathrm{mRNA}} t) $$\nThe derivative is:\n$$ \\frac{dE_{\\mathrm{mRNA}}}{dt} = -A \\lambda_{\\mathrm{mRNA}} \\exp(-\\lambda_{\\mathrm{mRNA}} t) $$\nSince $A > 0$ and $\\lambda_{\\mathrm{mRNA}} > 0$, this derivative is always negative for $t \\ge 0$. A strictly decreasing function on the interval $[0, \\infty)$ has its maximum at the start of the interval.\n$$ t_{\\mathrm{mRNA}}^{\\ast} = 0 \\, \\mathrm{h} $$\n\n**Time $t_{\\mathrm{pDNA}}^{\\ast}$**\n$$ E_{\\mathrm{pDNA}}(t) = B \\left( \\exp(-\\lambda_{\\mathrm{pDNA}} t) - \\exp(-\\lambda_{\\mathrm{mRNA}} t) \\right) $$\nThe derivative is:\n$$ \\frac{dE_{\\mathrm{pDNA}}}{dt} = B \\left( -\\lambda_{\\mathrm{pDNA}} \\exp(-\\lambda_{\\mathrm{pDNA}} t) + \\lambda_{\\mathrm{mRNA}} \\exp(-\\lambda_{\\mathrm{mRNA}} t) \\right) $$\nSet the derivative to zero to find the critical point:\n$$ -\\lambda_{\\mathrm{pDNA}} \\exp(-\\lambda_{\\mathrm{pDNA}} t_{\\mathrm{pDNA}}^{\\ast}) + \\lambda_{\\mathrm{mRNA}} \\exp(-\\lambda_{\\mathrm{mRNA}} t_{\\mathrm{pDNA}}^{\\ast}) = 0 $$\n$$ \\lambda_{\\mathrm{mRNA}} \\exp(-\\lambda_{\\mathrm{mRNA}} t_{\\mathrm{pDNA}}^{\\ast}) = \\lambda_{\\mathrm{pDNA}} \\exp(-\\lambda_{\\mathrm{pDNA}} t_{\\mathrm{pDNA}}^{\\ast}) $$\n$$ \\frac{\\exp(-\\lambda_{\\mathrm{mRNA}} t_{\\mathrm{pDNA}}^{\\ast})}{\\exp(-\\lambda_{\\mathrm{pDNA}} t_{\\mathrm{pDNA}}^{\\ast})} = \\frac{\\lambda_{\\mathrm{pDNA}}}{\\lambda_{\\mathrm{mRNA}}} $$\n$$ \\exp((\\lambda_{\\mathrm{pDNA}} - \\lambda_{\\mathrm{mRNA}}) t_{\\mathrm{pDNA}}^{\\ast}) = \\frac{\\lambda_{\\mathrm{pDNA}}}{\\lambda_{\\mathrm{mRNA}}} $$\nTaking the natural logarithm of both sides:\n$$ (\\lambda_{\\mathrm{pDNA}} - \\lambda_{\\mathrm{mRNA}}) t_{\\mathrm{pDNA}}^{\\ast} = \\ln\\left(\\frac{\\lambda_{\\mathrm{pDNA}}}{\\lambda_{\\mathrm{mRNA}}}\\right) $$\n$$ t_{\\mathrm{pDNA}}^{\\ast} = \\frac{\\ln(\\lambda_{\\mathrm{pDNA}} / \\lambda_{\\mathrm{mRNA}})}{\\lambda_{\\mathrm{pDNA}} - \\lambda_{\\mathrm{mRNA}}} = \\frac{-\\ln(\\lambda_{\\mathrm{mRNA}} / \\lambda_{\\mathrm{pDNA}})}{-(\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}})} = \\frac{\\ln(\\lambda_{\\mathrm{mRNA}} / \\lambda_{\\mathrm{pDNA}})}{\\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}}} $$\nThe second derivative test confirms this is a maximum.\n\nNow, we substitute the numerical values for the rate constants.\nThe ratio of the rate constants is:\n$$ \\frac{\\lambda_{\\mathrm{mRNA}}}{\\lambda_{\\mathrm{pDNA}}} = \\frac{(\\ln 2)/6}{(\\ln 2)/24} = \\frac{24}{6} = 4 $$\nThe difference of the rate constants is:\n$$ \\lambda_{\\mathrm{mRNA}} - \\lambda_{\\mathrm{pDNA}} = \\frac{\\ln 2}{6} - \\frac{\\ln 2}{24} = \\ln 2 \\left(\\frac{4-1}{24}\\right) = \\frac{3 \\ln 2}{24} = \\frac{\\ln 2}{8} \\, \\mathrm{h}^{-1} $$\nSubstituting these into the expression for $t_{\\mathrm{pDNA}}^{\\ast}$:\n$$ t_{\\mathrm{pDNA}}^{\\ast} = \\frac{\\ln(4)}{\\frac{\\ln 2}{8}} = \\frac{2 \\ln 2}{(\\ln 2)/8} = 2 \\times 8 = 16 \\, \\mathrm{h} $$\nThe peak time for the plasmid DNA modality is exactly $16\\,\\mathrm{h}$.\n\n**Final Numerical Answer**\nThe problem requires the answers to be rounded to four significant figures.\n$t_{\\mathrm{mRNA}}^{\\ast} = 0\\,\\mathrm{h}$. To present this with four significant figures, we write $0.0000$.\n$t_{\\mathrm{pDNA}}^{\\ast} = 16\\,\\mathrm{h}$. To present this with four significant figures, we write $16.00$.\n\nThe final answer is the row matrix $\\begin{pmatrix} t_{\\mathrm{mRNA}}^{\\ast} & t_{\\mathrm{pDNA}}^{\\ast} \\end{pmatrix}$.\n$$ \\begin{pmatrix} 0.0000 & 16.00 \\end{pmatrix} $$",
            "answer": "$$ \\boxed{ \\begin{pmatrix} 0.0000 & 16.00 \\end{pmatrix} } $$"
        }
    ]
}